Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
304 participants
OBSERVATIONAL
2008-09-29
2017-06-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients with VACTERL association and their parents and siblings may be eligible for this study.
Patients are admitted to the NIH Clinical Center for evaluation over 3 to 4 days that may include the following procedures:
* Physical examination, medical history, electrocardiogram (EKG), blood and urine tests
* Eye examination
* Imaging studies (echocardiogram, x-rays and ultrasound tests)
* Other specialized tests or consultations as indicated
* Optional medical photographs of the face and other body parts that may be involved in VACTERL association for publication in scientific texts or for teaching purposes
* Optional return visit after 2 years for repeat testing and to look for changes over time
Parents of patients have the following procedures:
* Physical examination, medical history, blood tests and x-rays, if needed
* Specialty consultations as indicated
* Optional medical photographs of the face and other body parts that may be involved in VACTERL association for publication in scientific texts or for teaching purposes
* Questionnaires about their child s medical history, growth, behavior and development, therapy and medication
Siblings of patients have the following procedures:
* Physical examination, medical history and blood tests
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic Analysis of Neural Tube and Orofacial Cleft Defects in the Irish Population
NCT00341068
Genetic Analysis of Left-Right Axis Formations
NCT00341133
Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome
NCT00075348
Personalized Genomic Research
NCT01294345
Retrospective Review of the Outcomes of Newborns With Genetic Abnormalities
NCT00366821
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Two features of VACTERL association in an index case plus at least 1 feature of VACTERL association in a relative OR
3. At least 2 features of VACTERL association in an index case plus at least 1 other anomaly.
(B) First degree relatives (parents and/or siblings of affected individuals) of patients with VACTERL association are also eligible to participate in portions of the protocol even if they have no features of VACTERL association.
Exclusion Criteria
2. Cases that are clearly not in the spectrum of VACTERL association or related to our direct research interests (e.g. referred VACTERL cases that are felt to be related to other syndromes, such as Feingold syndrome, Townes-Brocks syndrome, or Pallister-Hall syndrome, would not be included). In such instances, we would attempt to make referrals to a more appropriate investigator.
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Human Genome Research Institute (NHGRI)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maximilian Muenke, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Human Genome Research Institute (NHGRI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Arsic D, Beasley SW, Sullivan MJ. Switched-on Sonic hedgehog: a gene whose activity extends beyond fetal development--to oncogenesis. J Paediatr Child Health. 2007 Jun;43(6):421-3. doi: 10.1111/j.1440-1754.2007.01104.x.
Arsic D, Qi BQ, Beasley SW. Hedgehog in the human: a possible explanation for the VATER association. J Paediatr Child Health. 2002 Apr;38(2):117-21. doi: 10.1046/j.1440-1754.2002.00813.x.
Botto LD, Khoury MJ, Mastroiacovo P, Castilla EE, Moore CA, Skjaerven R, Mutchinick OM, Borman B, Cocchi G, Czeizel AE, Goujard J, Irgens LM, Lancaster PA, Martinez-Frias ML, Merlob P, Ruusinen A, Stoll C, Sumiyoshi Y. The spectrum of congenital anomalies of the VATER association: an international study. Am J Med Genet. 1997 Jul 11;71(1):8-15. doi: 10.1002/(sici)1096-8628(19970711)71:13.0.co;2-v.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08-HG-0224
Identifier Type: -
Identifier Source: secondary_id
080224
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.